Home › Trial NCT03484221
Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer
- Trial IDNCT03484221
- StatusUnknown
- PhasePhase 2
- Study typeInterventional
- SponsorChina Medical University, China
- Enrollment30
- Start date2018-04-01
- ConditionsRectal Neoplasms · Drug Therapy · Radiation
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.